COMMUNIQUÉS West-GlobeNewswire

-
NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process
15/08/2024 -
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15/08/2024 -
Beacon Behavioral Partners Expands to Pennsylvania with Partnership of Nexus Group
15/08/2024 -
Canadian Red Cross announces additional financial assistance for people impacted by wildfires in Jasper, Alberta
15/08/2024 -
La Croix-Rouge canadienne annonce une aide financière additionnelle pour les personnes touchées par les feux de forêt à Jasper, en Alberta
15/08/2024 -
CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
15/08/2024 -
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
15/08/2024 -
Claritas HealthTech Taps Mach7 Technologies Founder, Ravi Krishnan, to Head the Global Deployment of Providence AI, its Platform for Universal Medical AI Tools Development
15/08/2024 -
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
15/08/2024 -
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
15/08/2024 -
Protect Pharmaceutical Corp. (PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger
15/08/2024 -
Capsa Announces Expansion In Retail Pharmacy Central Fill Automation
15/08/2024 -
NutrifyGenie by Nutrify Today Establishes New AI Standards in Dietary Supplement Development
15/08/2024 -
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
15/08/2024 -
Aligos Therapeutics Announces Reverse Stock Split
15/08/2024 -
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
15/08/2024 -
Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
15/08/2024 -
International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific Assembly
15/08/2024 -
Sienna Announces August Dividend
15/08/2024
Pages